Novartis to invest $23 billion on expansion of manufacturing and R&D facilities in US
Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities
Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities
This facility represents a significant step in Croda’s Pharma business strategy to ‘Empower biologics delivery’
It will bring together renowned global experts in the field to discuss groundbreaking advances in biomaterials and their clinical applications
The project will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines
Dr. Smith brings 30 years of clinical and translational research experience in obesity, diabetes, and metabolism with over 300 scientific publications
Acquisition expands high-value medical platform
The technical program will run in four sessions and a panel discussion on “Challenges in translation of medical technologies”
Studies suggest that the protein Sclerostin plays a key role in the dysregulation of bone metabolism
Subscribe To Our Newsletter & Stay Updated